To read this content please select one of the options below:

Does CSR matter in the pharmaceutical distribution industry? The balanced scorecard perspective

Gholamhossein Mehralian (Department of Pharmacoeconomic and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran)
Leila Zarei (Department of Pharmacoeconomic and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran)
Mehdi Akhgari (University Canada West, Vancouver, British Columbia, Canada)
Mohammd Peikanpour (Department of Pharmacoeconomic and Pharma Management, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran)

International Journal of Pharmaceutical and Healthcare Marketing

ISSN: 1750-6123

Article publication date: 20 May 2019

Issue publication date: 17 June 2019

646

Abstract

Purpose

Given the important role of corporate social responsibility (CSR) in today’s business world, this study aims to investigate how it affects the performance of pharmaceutical distribution companies by using the balanced scorecard (BSC).

Design/methodology/approach

Drawing upon the existing literature, a questionnaire consisting of 32 questions was prepared and distributed to examine ongoing practices and to probe uninvestigated domains related to CSR. To confirm the efficiency of the research model and the accuracy of the measurement model – which was utilized to examine the correlation between different variables – variable scores were acquired from a national study and were entered into a structural equation model.

Findings

Analysis of 933 completed questionnaires revealed the existence of large correlation between subsets of the considered dimensions. The questionnaire contained five underlying dimensions: employee relations, corporate governance, societal concern, economic and financial concern and environmental concerns. All CSR variables can be condensed into these five dimensions, which are the main features of the CSR model proposed for the Iranian pharmaceutical distribution companies. Not only did the results support the research model but also indicated that CSR’s impact on BSC and its four components – financial perspective, customer perspective, internal process perspective and learning and growth perspective – was both positive and significant.

Practical implications

This paper identifies five dimensions through which CSR practices can effect positive changes in an organization’s performance in relation to the four BSC perspectives. Thus, in focusing on these dimensions, a company increases its likelihood of enhancing its performance and, consequently, realizing significant gains. In addition, as managers play the most significant role in CSR implementation, they should support all associated practices to achieve their strategic goals.

Originality/value

Pharmaceutical distribution companies tend to apply CSR – which is commonly described as informal and voluntary humanitarian activities – to different domains, including the workplace, marketplace, community and environment. This study contributes to the existing literature by shedding light on various domains in which CSR practices are applied to enhance organizational success in pharmaceutical distribution companies.

Keywords

Citation

Mehralian, G., Zarei, L., Akhgari, M. and Peikanpour, M. (2019), "Does CSR matter in the pharmaceutical distribution industry? The balanced scorecard perspective", International Journal of Pharmaceutical and Healthcare Marketing, Vol. 13 No. 2, pp. 228-243. https://doi.org/10.1108/IJPHM-05-2017-0028

Publisher

:

Emerald Publishing Limited

Copyright © 2019, Emerald Publishing Limited

Related articles